Long‐Term Antibiotic Treatment for Crohn's Disease: Systematic Review and Meta‐Analysis of Placebo‐Controlled Trials
about
Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?Epidemiology and clinical course of Crohn's disease: results from observational studiesPrimary treatment of Crohn’s disease: combined antibiotics taking center stageMycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammationMultidrug Resistance Is Common in Escherichia coli Associated with Ileal Crohnʼs DiseaseAnti-tuberculous therapy for maintenance of remission in Crohn's diseaseUse of rifaximin in gastrointestinal and liver diseasesIntestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease PathogenesisNod2: A Critical Regulator of Ileal Microbiota and Crohn's DiseaseMycobacterium paratuberculosis as a cause of Crohn's diseaseProtective and pro-inflammatory roles of intestinal bacteriaHost genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiotaUncommon acquired fistulae involving the digestive system: summary of data.Spontaneous remission of Crohn's disease following a febrile infection: case report and literature review.Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestineMedical management of Crohn's disease.Microbial imbalance and intestinal pathologies: connections and contributionsCurrent and emerging drugs for the treatment of inflammatory bowel disease.Role of the enteric microbiota in intestinal homeostasis and inflammationTreatment of refractory Crohn's disease and pyoderma gangrenosum with a combination regimen of rifaximin, gentamicin and metronidazoleCharacteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel diseaseGut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis.Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Attacking the system: Next-generation auto-immune therapies target pathways rather than symptoms.Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chrA mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.Campylobacter concisus - A new player in intestinal disease.Patient outcomes after anti TNF-alpha drugs for Crohn's disease.Current perspectives on Mycobacterium avium subsp. paratuberculosis, Johne's disease, and Crohn's disease: a review.Review article: remission rates achievable by current therapies for inflammatory bowel disease.Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.Efficacy and safety of adalimumab in Crohn's disease: meta-analysis of placebo-controlled trials.Crohn's disease and the mycobacterioses: a quarter century later. Causation or simple association?Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.The role of anti(myco)bacterial interventions in the management of IBD: is there evidence at all?Comparing medical treatments for Crohn's disease.Inflammatory bowel disease meta-evidence and its challenges: is it time to restructure surgical research?Mycobacterium avium ss. paratuberculosis Zoonosis - The Hundred Year War - Beyond Crohn's Disease.Gene-environment interactions in inflammatory bowel disease: microbiota and genes.
P2860
Q21198788-A406ACBF-1C3D-43C7-A142-D33345198E0DQ22241217-EFF8DB3A-B01E-4335-B4ED-B4A6FE39780EQ22241483-38E2B1A1-6561-4F44-BFDE-1E0671801D74Q22241484-6138FD34-5880-43F3-BEC4-D94A86647ADCQ22252899-FDE0E11B-CE25-4BB0-876D-B926EA6B8395Q26471031-5338FD66-8564-4F24-AF9D-55E594D298D5Q26740201-93B3963B-014D-43F3-87DB-8A06D7F84594Q26781239-7F967769-9809-43A7-9CE2-59527D48EDBDQ28079236-5165E122-F738-413E-830A-505358C0DAD8Q28081602-1D03C9FF-7046-4A4F-B87B-6F94DAC9B326Q28273923-0443D209-8B9E-4873-B6A2-B847B0CA7F4FQ28732754-A1B89D55-3E06-485A-9FD0-E2B24674ADFAQ31040283-A5F3E4C9-53B0-4FD9-9A1A-4FA2CA5F494EQ33904884-4F551336-4D09-4E21-9E77-0D2872DE33EDQ33996821-FB092880-AE12-492B-8864-85CC6CD8C0A4Q34046139-F9578076-A902-453F-BEEE-4BB0C346B2FAQ34241115-BE760367-445B-4CB8-A4EE-11F3FDCEC205Q34883210-86E2FF16-52AB-498E-8C61-4DA5A85541EBQ35052712-0D81F585-A102-477F-A582-A7585203729AQ35127966-EFEFF6D5-B6EF-40DA-9EB7-F9C10275833DQ35224329-54160071-0441-4EF3-9D4D-9F5BA99BCD48Q35228714-9F074020-CBD3-4533-98CF-848879827759Q35270551-C377A97B-432B-4EB2-80A9-B273D1D8F396Q35271319-DACF8C4D-86D3-4193-8D02-7A84C76E1E30Q35302980-0EDA47FC-04C6-4FFE-B052-7037AC552054Q35693684-FF0437EC-AB55-4CD1-AC4E-FD68120584B1Q35901531-B0278C55-A057-4287-8E42-34937DDEFAA2Q36158897-CB849059-A551-497C-8358-0C2A5905EDF4Q37729206-A812DBB6-B6DC-490B-A94A-94C0108784C5Q37831300-00F84074-1AA4-4670-BEC2-85238EBFE6C3Q37842605-33DFCDBE-5E27-438A-BAC2-8B13558CF066Q37853361-CEBFDBD1-E566-433D-832F-B10406050A8FQ37880288-2DCF1896-D431-4CA1-99B3-EA15B186C9DEQ37975540-08B92D47-13BD-4977-A0C3-67EE9A0BF2C1Q37991389-D0D36152-23A1-47E7-81D4-40BA6078E3B0Q38026395-BB1EF157-A12D-4627-85BD-5A1BD7C0FD18Q38162880-469E445C-EE1D-4DCC-9436-7F0BABF801F0Q38302725-FE52039A-81A1-43F7-A5BA-A0A64D273907Q38383625-0E9E807D-F39D-4C32-9079-EDE3700C61CCQ41060621-4C7F7A2D-98A2-4325-BB26-D8D831D96681
P2860
Long‐Term Antibiotic Treatment for Crohn's Disease: Systematic Review and Meta‐Analysis of Placebo‐Controlled Trials
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@ast
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@en
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@nl
type
label
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@ast
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@en
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@nl
altLabel
Long-term antibiotic treatment ...... s of placebo-controlled trials
@en
prefLabel
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@ast
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@en
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@nl
P2093
P31
P50
P921
P3181
P356
P1476
Long‐Term Antibiotic Treatment ...... s of Placebo‐Controlled Trials
@en
P2093
Aijing Shang
Alain Schoepfer
Karin Huwiler
P304
P3181
P356
10.1086/649923
P407
P577
2010-02-15T00:00:00Z